Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer

por Tan, Ruoding, Yun, Cindy, Seetasith, Arpamas, Sheinson, Daniel, Walls, Robert, Ngwa, Innocent, Reddy, Josina C, Zhang, Qing, Secrest, Matthew H, Lambert, Peter, Sarsour, Khaled
Publicado 2022

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

por Kim, Edward S., Velcheti, Vamsidhar, Mekhail, Tarek, Yun, Cindy, Shagan, Sarah M., Hu, Sylvia, Chae, Young Kwang, Leal, Ticiana A., Dowell, Jonathan E., Tsai, Michaela L., Dakhil, Christopher S. R., Stella, Philip, Jin, Yanling, Shames, David S., Schleifman, Erica, Fabrizio, David A., Phan, See, Socinski, Mark A.
Publicado 2022